[link removed]
This month’s epilepsy research news includes a study examining the efficacy of cognitive behavioral therapy that is designed specifically to treat individuals with psychogenic nonepileptic seizures ([link removed]) (PNES).
In addition, recent research documents the ability of a wearable device called an accelerometer ([link removed]) to assess the risk of life-threatening complications associated with seizures, such as Sudden Unexpected Death in Epilepsy (SUDEP). In the same spirit of technological advances, a recently published study discusses assessment of predictive models and underlying factors to assist seizure-free patients and their clinicians in safely withdrawing from antiepileptic drugs (AEDs).
Finally, we spotlight a study suggesting that autism and epilepsy ([link removed]) may share neurodevelopmental origins. This work was co-led by Dr. Jamie Capal, who presented a CURE webinar on this work, which you can watch here ([link removed]) .
** Research News
------------------------------------------------------------
* Promising Treatment for PNES: PNES are involuntary episodes that look and feel similar to epileptic seizures but have psychological, not neurological, causes. Researchers have found that adding PNES-specific cognitive behavioral therapy (CBT) to standardized medical care for patients who suffer from these debilitating episodes results in longer periods of seizure freedom and significantly improved quality of life. Learn More ([link removed])
* Wearable Devices and SUDEP Risk Assessment: An accelerometer (ACC) is a wearable device that measures motion during a convulsive seizure. This study now shows that the “silence” recorded by ACCs after a seizure is a reliable indicator of “post-ictal immobility” (PI) which is the absence of motion following a seizure. PI has been associated with potentially life-threatening complications, including SUDEP. Learn More ([link removed])
* Antiepileptic Drug (AED) Withdrawal: People with epilepsy who have been seizure-free for 1-2 years and stop taking their AEDs face a risk of recurrent seizures, the likelihood of which is difficult to determine. The authors of this study investigated five risk prediction models and predictive variables to assist in the development of personalized AED withdrawal plans. Learn More ([link removed])
* Epilepsy and Autism: A study shows that early behavioral signs may predict the development of epilepsy in children with autism, suggesting the two disorders may share common origins. Nevertheless, the authors caution that there are not enough data for clinicians to start using these behavioral indicators as a screening tool. Learn More ([link removed])
------------------------------------------------------------
Get epilepsy research news in the palm of your hand! Download the CURE epilepsy research mobile app on iOS ([link removed]) or Android ([link removed]) .
------------------------------------------------------------
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed] [link removed] [link removed] [link removed] [link removed]
View this email in your browser. ([link removed])
Our mailing address is:
Citizens United for Research in Epilepsy (CURE)
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Update your preferences ([link removed]) or unsubscribe from this list ([link removed])
In the past you provided Citizens United for Research in Epilepsy your email address. Occasionally, you will receive updates from CURE about epilepsy research and news.
